“As you can see, dementia is almost absent in the calcineurin inhibitor group.”
One Texas hospital found almost no dementia in transplant patients on a common class of immunosuppressants. Nationwide Medicare data on kidney recipients found normal dementia rates. That is the “maybe” in the headline doing all the work. The author discloses that his own company is raising money to put a cyclosporine variant into trials, so read the enthusiasm as a pitch.